Genome-wide association studies and the clinic: a focus on breast cancer (Q22064616)

7 February 2023

Amélie Véron

1

Amélie

Véron

1 reference

24521025

7 February 2023

Sophie Blein

series ordinal

2

author given names

Sophie

author last names

Blein

1 reference

24521025

7 February 2023

language of work or name

English

0 references

publication date

February 2014

0 references

published in

Biomarkers in Medicine

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

volume

8

0 references

issue

2

0 references

page(s)

287-296

0 references

cites work

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A genome-wide scan for breast cancer risk haplotypes among African American women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Migration patterns and breast cancer risk in Asian-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

21 January 2018

Familial breast cancer.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Linkage of early-onset familial breast cancer to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Lifetime cancer risks in individuals with germline PTEN mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Frequency and spectrum of cancers in the Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Breast cancer susceptibility: current knowledge and implications for genetic counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A common coding variant in CASP8 is associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Complement factor H polymorphism in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Evaluation of coverage variation of SNP chips for genome-wide association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Multiple loci with different cancer specificities within the 8q24 gene desert

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Frequent multiplication of chromosomal region 8q24.1 associated with aggressive histologic types of breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

The 8q24 gene desert: an oasis of non-coding transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

The randomized trials of breast cancer screening: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Effect of three decades of screening mammography on breast-cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Hormone therapy and breast cancer risk 10 years after the WHI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

American Cancer Society guidelines for breast cancer screening: update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Performance of common genetic variants in breast-cancer risk models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Transcription of Ti plasmid-derived sequences in three octopine-type crown gall tumor lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Genome-wide association analysis identifies three new breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Sample size requirements for indirect association studies of gene-environment interactions (G x E).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Sample size requirements to detect gene-environment interactions in genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

BOOST: A fast approach to detecting gene-gene interactions in genome-wide case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Detecting purely epistatic multi-locus interactions by an omnibus permutation test on ensembles of two-locus analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A novel method to identify high order gene-gene interactions in genome-wide association studies: gene-based MDR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Genome-wide association analysis by lasso penalized logistic regression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A Bayesian measure of the probability of false discovery in genetic epidemiology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Using prior information from the medical literature in GWAS of oral cancer identifies novel susceptibility variant on chromosome 4--the AdAPT method

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Linking disease associations with regulatory information in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Integrative eQTL-based analyses reveal the biology of breast cancer risk loci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Epidemiology and pathophysiology of alcohol and breast cancer: Update 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Hormonal contraception and risk of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Genome-wide association study identifies five new breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A genome-wide association scan on estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Common breast cancer susceptibility loci are associated with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Identification of a novel percent mammographic density locus at 12q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Mammographic breast density and breast cancer: evidence of a shared genetic basis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Polygenes, risk prediction, and targeted prevention of breast cancer

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Validation studies on a model for breast cancer risk

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Exploiting gene-environment interaction to detect genetic associations

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Trends in breast cancer screening and diagnosis.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Screening for breast cancer: recommendations and rationale

1 reference

https://api.crossref.org/works/10.2217%2FBMM.13.121

7 January 2021

Identifiers

DOI

10.2217/BMM.13.121

0 references